It also looks like it has only just hit the market going by Pumps instagram posts. The deal was signed in June for 10,000 units so I suppose a few things had to be done before hitting the market with their clinically proven product thanks to Cellmid and its research team. I can imagine those units rocking out the door and Pump putting in another order. My gut also tells me that the new supplement will be heading Pumps way.
Thanks for putting up a post that won’t drive people away Pharma.
Ann: FGF5 Inhibitors Supply Agreement - Additional Information, page-32
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 104978 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 7500 | 1 |
View Market Depth
| Last trade - 16.12pm 06/08/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable